Genus Claiming (Including Means Plus Function “MPF” Claiming) in Biotech and Pharma: Doctrinal Trajectory and Drafting Strategies
June 2026
LES Japan News
Finnegan attorney Chiaki Kobayashi authored an article titled, “Genus Claiming (Including Means Plus Function “MPF” Claiming) in Biotech and Pharma: Doctrinal Trajectory and Drafting Strategies” for the June 2026 issue of LES Japan News, a journal of Licensing Executive Society Japan. Finnegan partner John D. Livingstone edited the article. The link to the full article (Japanese only) can be found here. (Vol. 67, No. 2, June 2026, pp. 32-50).
Related Industries
Related Offices
Related Professionals
- Chiaki Kobayashi
- Partner
- Tokyo
- + 813 3 431 6525
Originally printed in LES Japan News, a journal of Licensing Executive Society Japan, in its June 2026 issue. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.